US Stock MarketDetailed Quotes

CRDF Cardiff Oncology

Watchlist
  • 2.425
  • +0.075+3.19%
Trading Jul 23 13:57 ET
108.49MMarket Cap-2694P/E (TTM)

Cardiff Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
10.61%-7.74M
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
-36.98%-7.49M
-55.66%-6.7M
Net income from continuing operations
10.80%-10.01M
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
-54.55%-10.44M
Operating gains losses
----
----
----
----
----
----
100.35%1K
----
----
----
Depreciation and amortization
13.33%102K
68.64%398K
19.77%103K
32.10%107K
157.89%98K
190.32%90K
-47.67%236K
-23.89%86K
-26.36%81K
-65.14%38K
Other non cash items
----
----
----
----
----
----
-93.16%139K
--0
--0
--0
Change In working capital
-23.65%1.2M
1,828.42%6.57M
179.39%1.39M
791.22%1.02M
5.61%2.58M
270.24%1.57M
78.76%-380K
-8,660.00%-1.75M
76.55%-148K
636.14%2.44M
-Change in receivables
-210.53%-105K
304.66%483K
25.62%-90K
62.63%-37K
595.19%515K
7.95%95K
-9.77%-236K
14.18%-121K
-15.12%-99K
-55.22%-104K
-Change in prepaid assets
-107.59%-95K
815.35%3.17M
95.75%-19K
6,728.57%928K
-12.94%1.01M
209.64%1.25M
78.89%-443K
67.08%-447K
98.27%-14K
361.75%1.16M
-Change in payables and accrued expense
597.04%1.42M
110.01%2.83M
6,000.00%1.4M
421.43%135K
-20.26%1.09M
--203K
87.48%1.35M
-98.52%23K
-114.43%-42K
355.67%1.37M
-Change in other current assets
-14.81%138K
207.96%651K
122.80%243K
0.73%138K
-22.30%108K
-13.37%162K
-178.01%-603K
-946.03%-1.07M
-59.82%137K
139.66%139K
-Change in other current liabilities
-10.14%-152K
-26.91%-566K
-3.55%-146K
-8.46%-141K
-20.51%-141K
-137.93%-138K
53.88%-446K
28.06%-141K
64.67%-130K
44.29%-117K
Cash from discontinued investing activities
Operating cash flow
10.61%-7.74M
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
-36.98%-7.49M
-55.66%-6.7M
Investing cash flow
Cash flow from continuing investing activities
-36.74%4.64M
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
-35.86%5.16M
140.03%7.61M
Capital expenditure reported
-900.00%-80K
42.15%-582K
89.33%-8K
29.69%-315K
19.55%-251K
95.32%-8K
-390.73%-1.01M
29.91%-75K
-357.14%-448K
---312K
Net investment purchase and sale
-35.72%4.72M
-5.80%36.78M
91.25%13.57M
-25.72%4.14M
49.51%11.74M
-60.40%7.34M
129.75%39.04M
181.67%7.1M
-31.66%5.57M
141.30%7.85M
Net other investing changes
----
----
----
----
----
----
--114K
--0
--43K
----
Cash from discontinued investing activities
Investing cash flow
-36.74%4.64M
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
-35.86%5.16M
140.03%7.61M
Financing cash flow
Cash flow from continuing financing activities
107K
0
0
0
-99.79%75K
0
Proceeds from stock option exercised by employees
--107K
--0
--0
----
----
--0
-94.06%75K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--107K
--0
--0
--0
--0
--0
-99.79%75K
--0
--75K
--0
Net cash flow
Beginning cash position
32.47%21.66M
36.88%16.35M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
-90.88%11.94M
42.17%18.72M
98.14%20.97M
36.76%20.05M
Current changes in cash
-125.34%-3M
20.53%5.31M
370.97%6.42M
-83.99%-4.14M
376.67%4.35M
-116.40%-1.33M
103.70%4.4M
-93.94%-2.37M
-187.00%-2.25M
122.37%913K
End cash Position
24.25%18.66M
32.47%21.66M
32.47%21.66M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
36.88%16.35M
42.17%18.72M
98.14%20.97M
Free cash flow
9.77%-7.82M
9.64%-31.47M
24.49%-7.15M
-4.26%-8.27M
-5.37%-7.38M
16.82%-8.67M
-49.82%-34.83M
-26.25%-9.47M
-42.62%-7.93M
-62.92%-7.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 10.61%-7.74M8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M-36.98%-7.49M-55.66%-6.7M
Net income from continuing operations 10.80%-10.01M-7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M-54.55%-10.44M
Operating gains losses ------------------------100.35%1K------------
Depreciation and amortization 13.33%102K68.64%398K19.77%103K32.10%107K157.89%98K190.32%90K-47.67%236K-23.89%86K-26.36%81K-65.14%38K
Other non cash items -------------------------93.16%139K--0--0--0
Change In working capital -23.65%1.2M1,828.42%6.57M179.39%1.39M791.22%1.02M5.61%2.58M270.24%1.57M78.76%-380K-8,660.00%-1.75M76.55%-148K636.14%2.44M
-Change in receivables -210.53%-105K304.66%483K25.62%-90K62.63%-37K595.19%515K7.95%95K-9.77%-236K14.18%-121K-15.12%-99K-55.22%-104K
-Change in prepaid assets -107.59%-95K815.35%3.17M95.75%-19K6,728.57%928K-12.94%1.01M209.64%1.25M78.89%-443K67.08%-447K98.27%-14K361.75%1.16M
-Change in payables and accrued expense 597.04%1.42M110.01%2.83M6,000.00%1.4M421.43%135K-20.26%1.09M--203K87.48%1.35M-98.52%23K-114.43%-42K355.67%1.37M
-Change in other current assets -14.81%138K207.96%651K122.80%243K0.73%138K-22.30%108K-13.37%162K-178.01%-603K-946.03%-1.07M-59.82%137K139.66%139K
-Change in other current liabilities -10.14%-152K-26.91%-566K-3.55%-146K-8.46%-141K-20.51%-141K-137.93%-138K53.88%-446K28.06%-141K64.67%-130K44.29%-117K
Cash from discontinued investing activities
Operating cash flow 10.61%-7.74M8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M-36.98%-7.49M-55.66%-6.7M
Investing cash flow
Cash flow from continuing investing activities -36.74%4.64M-5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M-35.86%5.16M140.03%7.61M
Capital expenditure reported -900.00%-80K42.15%-582K89.33%-8K29.69%-315K19.55%-251K95.32%-8K-390.73%-1.01M29.91%-75K-357.14%-448K---312K
Net investment purchase and sale -35.72%4.72M-5.80%36.78M91.25%13.57M-25.72%4.14M49.51%11.74M-60.40%7.34M129.75%39.04M181.67%7.1M-31.66%5.57M141.30%7.85M
Net other investing changes --------------------------114K--0--43K----
Cash from discontinued investing activities
Investing cash flow -36.74%4.64M-5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M-35.86%5.16M140.03%7.61M
Financing cash flow
Cash flow from continuing financing activities 107K000-99.79%75K0
Proceeds from stock option exercised by employees --107K--0--0----------0-94.06%75K--0--------
Cash from discontinued financing activities
Financing cash flow --107K--0--0--0--0--0-99.79%75K--0--75K--0
Net cash flow
Beginning cash position 32.47%21.66M36.88%16.35M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M-90.88%11.94M42.17%18.72M98.14%20.97M36.76%20.05M
Current changes in cash -125.34%-3M20.53%5.31M370.97%6.42M-83.99%-4.14M376.67%4.35M-116.40%-1.33M103.70%4.4M-93.94%-2.37M-187.00%-2.25M122.37%913K
End cash Position 24.25%18.66M32.47%21.66M32.47%21.66M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M36.88%16.35M42.17%18.72M98.14%20.97M
Free cash flow 9.77%-7.82M9.64%-31.47M24.49%-7.15M-4.26%-8.27M-5.37%-7.38M16.82%-8.67M-49.82%-34.83M-26.25%-9.47M-42.62%-7.93M-62.92%-7.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg